Liposomal methemoglobin as a potent antidote for hydrogen sulfide poisoning.

Abstract

Hydrogen sulfide (H2S) induces acute and lethal toxicity at high concentrations. However, no specific antidotes for H2S poisoning have been approved. Liposomal methemoglobin (metHb@Lipo) was developed as an antidote for cyanide poisoning. As the toxic mechanism of H2S poisoning is the same as that of cyanide poisoning, metHb@Lipo could potentially be used as an antidote for H2S poisoning. In this study, we evaluated the antidotal efficacy of metHb@Lipo against H2S poisoning. Stopped-flow rapid-scan spectrophotometry clearly showed that metHb@Lipo scavenged H2S rapidly. Additionally, metHb@Lipo showed cytoprotective effects against H2S exposure in H9c2 cells by maintaining mitochondrial function. MetHb@Lipo treatment also improved the survival rate after H2S exposure in vivo, with the maintenance of cytochrome c oxidase activity and suppression of metabolic acidosis. Moreover, metHb@Lipo therapy maintained significant antidotal efficacy even after 1-year-storage at 4-37 °C. In conclusion, metHb@Lipo is a candidate antidote for H2S poisoning.

• Authors: Yuto Suzuki, Kazuaki Taguchi, Tomoko Kure, Yuki Enoki, Masaki Otagiri, Hiromi Sakai, Kazuaki Matsumoto
• Journal: Toxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 450 Pg. 116159 (09 01 2022) ISSN: 1096-0333 [Electronic] United States
• PMID: 35803436 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 Elsevier Inc. All rights reserved.

Chemical References

• Antidotes
• Cyanides
• Methemoglobin
• Hydrogen Sulfide

Topics

• Antidotes (pharmacology, therapeutic use)
• Cyanides
• Humans
• Hydrogen Sulfide (metabolism)
• Methemoglobin (metabolism, pharmacology)
• Poisoning (drug therapy)